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Introduction
The reported incidence of ocular manifestations in patients 
with inflammatory bowel disease (IBD) is variable, ranging 
from 0.3% to 13%, 1.6% to 5.4% among those with ulcerative 
colitis and 3.5% to 6.8% among those with Crohn’s disease,1 
and may be primary, secondary to treatment, effects of the 
intestinal disease or coincidental.2,3 Ocular complications occur 
more frequently in patients with Crohn’s disease,4,5 rather than 
ulcerative colitis, and an association has been reported with 
female sex.1,5 Patients with a colonic or ileocolonic disease 
location tend to have a higher incidence of ocular involvement 
compared with those with only a small bowel disease loca-
tion.6,7 The presence of other extraintestinal manifestations 
(EIMs) such as arthralgia in Crohn’s disease has been associ-
ated with ocular involvement.8 Although episcleritis, scleritis, 
and uveitis are the most common ocular-EIMs (O-EIMs) in 
IBD,2 orbital inflammatory disease (OID) has also been 
reported as a rare EIM. Orbital inflammatory disease can pre-
sent with an array of findings depending on the structures 
affected by the combined effects of inflammation, elevated 
orbital pressure, and direct compression. Common findings 
include conjunctival injection, chemosis, eyelid swelling, prop-
tosis, diplopia, pain with eye movement, ophthalmoplegia, and 
impaired vision.3 Important differentials to consider in OID 
include malignancies, congenital mass lesions, orbital cellulitis, 
and occult or distant trauma. Systemic inflammatory diseases 
associations of OID include autoimmune thyroid disease, sar-
coidosis, granulomatosis with polyangiitis (GPA), systemic 
lupus erythematosus, and other connective tissue diseases.9 
Dacryoadenitis (localized inflammation of the lacrimal gland) 
is the rarest form of ocular adnexal involvement in IBD and 
typically presents with unilateral upper lid swelling, erythema, 
and pain in the superotemporal orbit.10–12 Herein, we report a 
rare case series of 3 female patients with Crohn’s disease devel-
oping heterogeneous manifestations of OID.
Case History 1
A 48-year-old woman was diagnosed with ileocolonic non-
stricturing, nonpenetrating Crohn’s disease at the age of 
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41 years. She described a 7-year history of joint pains and 
recurrent iritis preceding her diagnosis. Her prior treatments 
included 6-mercaptopurine, adalimumab, methotrexate, and a 
polymeric diet. While on a polymeric diet only due to previous 
drug intolerance issues and having stopped methotrexate 
2 weeks prior to her presentation, she presented with a 
2-month history of left lower eyelid swelling, diplopia, and 
ptosis. An orbital mass was palpable inferiorly which was 
causing elevation of the globe with reduced movement. Blood 
analysis revealed a raised white cell count (WCC) of 16 × 109/L 
and a C-reactive protein (CRP) of 300 mg/L. Computed 
tomography (CT) and subsequent magnetic resonance imag-
ing of the orbits revealed a well-defined lesion in the inferior 
aspect of the left orbit, involving the inferior rectus, without 
any other orbital abnormality (Figure 1A to D). Histopathologic 
assessment showed multiple noncaseating granulomas, some 
of which contained multinucleate giant cells (Figure 3A). 
Immunostaining was negative for Ziehl-Neelsen and IgG4. 
The patient was commenced on a 4-week reducing course of 
oral prednisolone, starting dose of 40 mg with recommence-
ment of weekly 15 mg subcutaneous methotrexate. After 
2 weeks of discharge, she was reviewed and noted to have 
made a full recovery with no recurrence of her luminal or 
orbital symptoms.
Case History 2
A 27-year-old woman was diagnosed with ileocolonic non-
stricturing, nonpenetrating Crohn’s disease at the age of 17 years. 
Figure 1. Orbital imaging in the 3 cases. Arrows indicate the site of the inflammatory masses. (A, B) Axial and coronal CT reformats of case 1. (C, D) 
Axial and coronal MRI of case 1. (E, F) Axial and coronal CT reformats of case 2. (G, H) Axial and coronal CT reformats of case 3. CT indicates computed 
tomography; MRI, magnetic resonance imaging.
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Other comorbidities included osteopenia, previous erythema 
nodosum, sinusitis, and a positive lupus anticoagulant result. 
Her family history included autoimmune hemolytic anemia, 
GPA, and tuberculosis. In the 4 years following diagnosis, her 
Crohn’s disease followed a steroid-refractory course compli-
cated by stricturing of the large intestine, leading to a segmen-
tal transverse colon resection and right-sided double-barrelled 
colostomy. After 1 year, she underwent a loop ileostomy for a 
perforated internal hernia. In the subsequent 5 years, additional 
surgeries were also performed for reversal of the loop ileostomy 
and subsequent refashioning of the colostomy. Her treatments 
included several courses of corticosteroids, azathioprine (devel-
oped intolerance), infliximab (anaphylaxis), and later adali-
mumab with addition of methotrexate. While off adalimumab 
for 1 week (recurrent viral infections), she presented with a 
2-day history of acute onset of bilateral painful S-shaped peri-
orbital swelling, moderate erythema, and chemosis worse on 
the left with diplopia (Figure 2A). Ocular movements were 
restricted and episcleritis was evident. A CT scan of head, 
orbits, and sinuses revealed bilateral lacrimal gland enlarge-
ment. Lateral and superior recti were also enlarged (Figure 1E 
to F). Blood analysis showed raised inflammatory markers with 
a WCC of 21.6 × 109/L and a CRP of 166 mg/L, normal serum 
angiotensin-converting enzyme (ACE) levels, and thyroid 
function. Immunologic tests showed positive perinuclear anti-
neutrophil cytoplasmic antibodies (p-ANCAs) and low pro-
teinase 3 (PR3). Neither pulmonary nor renal involvement was 
present. Postoperative appearances are shown in Figure 2B. 
Histology showed a chronic dacryoadenitis, acute vasculitis of 
medium-sized vessels, and necrotizing histiocytic granulomas 
(Figure 3B). Stains for periodic acid-Schiff-diastase, Ziehl-
Neelsen, and IgG4 were negative, and pus collected from the 
lacrimal gland during the biopsy did not reveal any microbial 
growth. The patient was started on a 2-day course of intrave-
nous Co-amoxiclav (1.2 g 3 times daily) and an 8-week reduc-
ing course of high-dose oral prednisolone (commencing at 
60 mg daily) for presumed OID complicating Crohn’s disease. 
Following recommencement of weekly 25 mg subcutaneous 
methotrexate and biweekly adalimumab, her symptoms and 
signs had completely resolved at ophthalmological assessment 
1 week later (Figure 2C).
Case History 3
A 33-year-old woman was diagnosed with colonic nonstrictur-
ing, nonpenetrating Crohn’s disease at the age of 21 years. 
Comorbidities included previous sinusitis. The patient was 
treated with azathioprine and subsequently infliximab 5 mg/kg 
every 7 weeks. Recently, she had experienced a relapse of her 
Crohn’s disease symptoms with endoscopic findings in keeping 
with active left-sided colonic disease. The patient presented 
with a 4-month history of left-sided swelling in the lacrimal 
gland area with typical S-shaped configuration, which had 
become more obvious over the preceding few days prior to hos-
pitalization. On examination, there was an S-shaped deformity 
Figure 2. Photographs of the patient in case 2 demonstrating the 
presenting signs and postoperative recovery. (A) At diagnosis, (B) 
immediately postoperatively, and (C) patient at 1-week post-discharge.
Figure 3. Representative histology using haematoxylin and eosin stain. 
(A) Orbital granuloma and (B) lacrimal granuloma with prominent vasculitis. 
Small arrow indicates granuloma, large outline arrow indicates vasculitis.
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of the left upper eyelid along with mild eyelid edema and a 
lobulated swelling of the lacrimal gland. Computed tomogra-
phy of the orbits showed an enlarged left lacrimal gland, which 
enhanced uniformly post-contrast (Figure 1G and H). Blood 
analysis showed a raised CRP of 55 mg/L. Histology revealed a 
dacryoadenitis featuring numerous, well-circumscribed nonca-
seating granulomas, some of which contained multinucleate 
giant cells. Special stains for microorganisms (Gram, Grocott, 
periodic acid-Schiff, and Ziehl-Neelsen) and IgG4 were nega-
tive. The presence of dacryoadenitis in the absence of a raised 
serum ACE level favored a diagnosis of an extraintestinal man-
ifestation of Crohn’s disease rather than sarcoidosis. The 
patient was commenced on a 2-day course of 100 mg twice 
daily flurbiprofen due to a previous psychotic reaction to corti-
costeroids followed by infliximab. Subsequent follow-up 
revealed complete resolution of symptoms aside from some 
residual scar tissue at the biopsy site.
Discussion
We report a case series of OID developing in 3 immunosup-
pressed female patients with active Crohn’s disease (Table 1). 
Orbital inflammatory disease is a rare EIM of IBD. 
Consequently, its exact association with clinical characteristics 
of the intestinal disease and patient demographics is uncer-
tain.5 In a review of 24 patients with biopsy-proven nonspe-
cific OID, the lacrimal gland was affected in 54.2%, extraocular 
muscles 50%, orbital fat 75%, sclera 4.2%, optic nerve 20.8%, 
and other structures in 8.3%.13 The histopathologic spectrum 
of nonspecific OID is typically nondiagnostic, secondary to a 
wide range of presentations ranging from diffuse polymor-
phous infiltrate to lymphoid, granulomatous, sclerosing, 
eosinophilic, or vasculitic inflammation.14
In our first and third cases, we observed unilateral orbital 
inflammatory changes. However, in case 2, bilateral orbital 
inflammation and a family history of vasculitis prompted an 
evaluation of systemic causes such as GPA, sarcoidosis, lym-
phoma, and IgG4-related disease. Although p-ANCAs were 
detected in case 2, patients with IBD are more likely to be 
p-ANCA positive than the general population, as are patients 
with idiopathic ocular inflammation with a family history of 
IBD.15 Perinuclear antineutrophil cytoplasmic antibodies are 
detected in 60% to 70% of ulcerative colitis cases, 10% to 15% 
of Crohn’s disease cases, and less than 5% of non-IBD colitis 
cases.16,17 Moreover, although histology demonstrated an acute 
necrotizing granulomatous vasculitis, this was not typical of a 
primary vasculitis and has been previously reported in OID.14 
However, association between GPA and Crohn’s disease has 
previously been described,18 albeit in the absence of orbital 
involvement.
Pathophysiological mechanisms of EIMs in IBD are not 
clearly understood and warrant further study. Proposed patho-
genetic autoimmune mechanisms include genetic susceptibil-
ity, antigenic display of autoantigen, aberrant self-recognition, 
and immunopathogenetic autoantibodies against organ-
specific cellular antigens shared by colon and the extraintesti-
nal organs.19 An immune response to a colonic antigen may 
Table 1. Clinical Features.
CASE 1 CASE 2 CASE 3
Crohn’s diagnosis (age) 41 17 21
Orbital inflammatory 
disease presentation (age)
48 27 33
Symptoms - Left lower eyelid swelling
- Double vision
- Bilateral periorbital swelling
- Pain
- Double vision
- Left upper eyelid 
swelling
Signs - Palpable orbital mass
- Restricted extraocular 
motility
- Globe elevation
- Left worse than right
- S-shaped upper eyelid edema
- Skin erythema
- Restricted extraocular motility
- Chemosis
- Episcleritis
- S-shaped upper 
eyelid edema
- Lobulated 
swelling of the 
lacrimal gland
Onset Gradual (mo) Acute (d) Gradual (mo)
Previous immunosuppr. 6-mercaptopurine, 
adalimumab, methotrexate
Steroids, azathioprine, infliximab, 
adalimumab + methotrexate
Azathioprine, 
infliximab
Imaging CT + MRI CT CT
Histopathology Noncaseating granulomas 
(mass)
Vasculitis of medium-sized vessels 
and necrotizing histiocytic 
granulomas (lacrimal gland)
Noncaseating 
granulomas (lacrimal 
gland)
Treatment Oral steroids Oral steroids Oral flurbiprofen
Abbreviations: CT, computed tomography; MRI, magnetic resonance imaging.
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explain why ocular manifestations occur more commonly with 
a colonic involvement.20 In cases 2 and 3, granulomatous 
dacryoadenitis may have arisen due to antigenic overlaps 
between gastrointestinal and lacrimal tissues, or alternatively, a 
gastrointestinal antigen may have localized hematogenously to 
the lacrimal glands’ location and incited a T-cell response, 
which produced an accompanying granulomatous reaction.12 
In relation to genetic susceptibility, one study found that 
the prevalence of a family history of IBD is 3 to 15-fold higher 
in patients with orbital inflammation than the general 
population.21 Other studies have reported major histocompat-
ibility complex associations with O-EIMs including human 
leucocyte antigen (HLA) haplotypes HLA-B27, B58, and 
HLA-DRB1*0103.22
Treatment of OID will depend on the extent of concomi-
tant intestinal disease and additional EIMs. Although resolu-
tion may occur with observation alone or with antibiotics, 
corticosteroid treatment as seen in cases 1 and 2 generally 
results in much faster resolution of symptoms and is reserved 
for moderate-to-severe disease.10 Treatment of IBD-associated 
orbital inflammation can also be achieved with immunosup-
pression such as azathioprine and methotrexate and, when 
refractory, responds well to anti-tumor necrosis factor therapy.2 
There are no reports on the efficacy of other licensed biological 
agents. It is therefore noteworthy that immunosuppression 
had been stopped in both cases 1 and 2 prior to developing 
orbital complications, which may have precipitated OID.
In conclusion, it is important to consider OID in the dif-
ferential diagnosis of patients with Crohn’s disease, present-
ing with periorbital swelling and ocular motility dysfunction. 
Care should be taken to exclude orbital cellulitis, IgG4-
related disease (with dacryoadenitis), lymphoproliferative 
and metastatic disease, sarcoidosis, and GPA. Patients pre-
senting with ocular complications of their IBD should be 
managed through the combined care of gastroenterology and 
ophthalmology services where clinical evaluation should 
include careful history, physical examination, appropriate 
laboratory and radiographic orbital investigations, as well as 
need for diagnostic biopsy.
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